The largest database of trusted experimental protocols

4 protocols using harringtonine

1

Characterization of Human Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T and HCT116 cells were cultivated in DMEM (#41966052, Thermo Fisher Scientific), SW480 and HT29 cells were cultivated in RPMI 1640 (#21875091, Thermo Fisher Scientific), supplemented with 10 % heat-inactivated FBS (#P30-2302, Pan Biotech) and 1% penicillin/streptomycin (#P4333, Sigma). All cell lines were purchased from ATCC. L17 R-spondin-producing cells were maintained in DMEM with 1 mg/ml G418 (#4727878001, Sigma). L17 R-spondin cells were a gift from Owen Sansom (Beatson Institute, Glasgow). All cell lines were authenticated via STR analysis in 2014.
Where specified, the following reagents were added: doxycycline (#D9891, Sigma), tunicamycin (#T7765, Sigma), cycloheximide (#C7698, Sigma), harringtonine (#sc-204771, Santa Cruz Biotechnology), 4-hydroxytamoxifen (#94873, Sigma), poly(I:C) (#tlrl-pic, Invivogen), GSK2606414 (Axon Medchem), A-92 (#2720, Axon Medchem), imidazolo-oxindole PKR inhibitor C16 (#I9785, Sigma).
+ Open protocol
+ Expand
2

Harringtonine-Puromycin Ribosome Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used harringtonine to block initiation followed by a short time course to observe translated products from preexisting elongating ribosomes, with puromycin termination and labeling [SunRiSE method (61 (link))]. Cells were divided into six-well plates and treated with harringtonine (2 μg/ml; Cayman Chemicals, catalog no. 26833-85-2). After indicated time of harringtonine treatment, cells were treated with puromycin (10 μg/ml; Santa Cruz Biotechnology, catalog no. CAS-58-58-2) for 8 min. Cells were pelleted, washed with cold PBS, and lysed in lysis buffer. Lysates were fractionated on a 4 to 20% gradient SDS-PAGE followed by immunoblotting. Anti-puromycin antibody (Kerafast) at a concentration of 1:1000 was used for immunoblotting. ImageJ was used to quantify the whole lane as well as the puromycin labeling of smaller proteins that report differences first (61 (link)).
+ Open protocol
+ Expand
3

Characterization of Human Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T and HCT116 cells were cultivated in DMEM (#41966052, Thermo Fisher Scientific), SW480 and HT29 cells were cultivated in RPMI 1640 (#21875091, Thermo Fisher Scientific), supplemented with 10 % heat-inactivated FBS (#P30-2302, Pan Biotech) and 1% penicillin/streptomycin (#P4333, Sigma). All cell lines were purchased from ATCC. L17 R-spondin-producing cells were maintained in DMEM with 1 mg/ml G418 (#4727878001, Sigma). L17 R-spondin cells were a gift from Owen Sansom (Beatson Institute, Glasgow). All cell lines were authenticated via STR analysis in 2014.
Where specified, the following reagents were added: doxycycline (#D9891, Sigma), tunicamycin (#T7765, Sigma), cycloheximide (#C7698, Sigma), harringtonine (#sc-204771, Santa Cruz Biotechnology), 4-hydroxytamoxifen (#94873, Sigma), poly(I:C) (#tlrl-pic, Invivogen), GSK2606414 (Axon Medchem), A-92 (#2720, Axon Medchem), imidazolo-oxindole PKR inhibitor C16 (#I9785, Sigma).
+ Open protocol
+ Expand
4

Ribosome Profiling and RNA-seq of Src-induced Cellular Transformation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 1 × 106 cells per 10-cm culture dish and cultured overnight. MCF10A-ER-Src cells were treated by 1 µM 4-hydroxy-tamoxifen for various time points (1, 4, and 24 hr) to induce transformation. Cells were pretreated with cycloheximide (100 µg/ml; Sigma-Aldrich, St. Louis, MO) for 90 s or harringtonine (2 µg/ml; Santa Cruz, Santa Cruz, CA) for 5 min, and detergent lysis was then performed with flash-freezing in liquid nitrogen. For ribosome profiling, DNase I-treated lysates were then treated with RNase I, and ribosome-protected fragments were purified for Illumina TruSeq library construction as previously described (Ingolia et al., 2012 (link)). For RNA-seq, total RNA was purified from DNase-treated lysates, and ribosomal RNA was depleted with RiboMinus Eukaryote Kit (Thermo Fisher Scientific, Waltham, MA). RNA-seq libraries were prepared with a tagging-based workflow (Pease and Kinross, 2013 ). In brief, rRNA-depleted RNA was fragmented at 85°C for 5 min, followed by cDNA synthesis, terminal tagging and PCR amplification with ScriptSeq v2 RNA-Seq Library Preparation Kit (Epicentre, Madison, WI). Ribosome profiling and RNA-seq libraries were sequenced with Illumina HiSeq 2500.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!